Clinical Trials Sponsored by Eugene Lee, MD

Total 78 results

Eugene Lee, MD
University of Kansas Medical Center

Completed

Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection

Bladder Cancer

United States
Lei Lei, MD

Recruiting

Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children. (ADHD)

Attention Deficit Disorder With Hyperactivity | Executive Function Disorder

China
Loma Linda University
Charles Lee MD; Michelle Schlunt MD

Withdrawn

Treatment of Postoperative Pain After Total Hip Arthroplasty Using Intravenous Lidocaine Infusion

Postoperative Pain Management After Total Hip Arthroplasty
Eugene Y Rhee, MD

Unknown

Efficacy of Promescent Lidocaine Spray in Men With Premature Ejaculation (Promescent)

Premature Ejaculation

United States
Lee Ocuin, MD

Not yet recruiting

CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)

Pancreas Adenocarcinoma | Pancreas Cancer

United States
Eugene F Yen, MD

Recruiting

Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis

Microscopic Colitis

United States
Gene Lee, MD
Medical University of South Carolina

Terminated

Cervical Pessary to Prevent Preterm Birth in Singleton Pregnancies With a Sonographically Measured Short Cervix

Premature Birth

United States
Richard W Yee, MD

Not yet recruiting

The Effects and Safety of Topical Spironolactone Ophthalmic Solution, 0.005 mg/cc in Subjects With Dry Eye Disease

Dry Eye Disease

United States
CHEOL WHAN LEE, MD, PhD.
CardioVascular Research Foundation, Korea

Completed

Comparison of Cilotax Stent and Everolimus -Eluting Stent With Diabetes Mellitus (ESSENCE-DM III)

Coronary Artery Disease

Korea, Republic of
CHEOL WHAN LEE, MD, PhD.

Terminated

Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina

Coronary Artery Diseases

Korea, Republic of
Andrew Moses Lee, MD, PhD

Recruiting

Cortical Stimulation to Treat Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder

United States
Andrew Moses Lee, MD, PhD

Not yet recruiting

Personalized DBS for OCD Guided by Stereoencephalography Mapping

Obsessive-Compulsive Disorder | OCD

United States
Richard W Yee, MD
Novartis Pharmaceuticals

Recruiting

The Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-versus-Host Disease

Graft-versus-host-disease | Ocular Graft-versus-host Disease

United States
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Unknown

Autologous Bone Marrow Concentration for Avascular Necrosis of Femoral Head

Bone Marrow | Avascular Necrosis of Femur

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Unknown

Autologous Bone Marrow Concentration for Rotator Cuff Tear

Rotator Cuff Tear | Bone Marrow

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet-rich Plasma for Low Back Pain

Discogenic Pain | Platelet-rich Plasma

Taiwan
H. Lee Moffitt Cancer Center and Research Institute
Celgene

Completed

Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene

Completed

Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)

Leukemia

United States
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Unknown

Autologous Bone Marrow Concentrate in Elective Tranforaminal Lumbar Interbody Fusion Surgery

Spinal Fusion | Bone Marrow

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Unknown

Autologous Bone Marrow Concentration for Femoral Shaft Fracture Union

Femoral Shaft Fracture | Bone Marrow

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet Rich Plasma for Knee Osteoarthritis

Osteo Arthritis Knee | Platelet-rich Plasma

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet-rich Plasma for Chronic Lateral Ankle Instability

Platelet-rich Plasma | Ankle Instability

Taiwan
Pei-Yuan Lee, MD
Aeon Biotechnology Corporation

Completed

Platelet-rich Plasma for Meniscus Repair

Knee Injuries | Platelet-Rich Plasma | Meniscus Disorder

Taiwan
H. Lee Moffitt Cancer Center and Research Institute
BeiGene

Recruiting

First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer

Prostate Cancer | Stage IV Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene

Completed

Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene

Completed

Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide

Myeloma

United States
MD Anderson International Spain SA
Celgene Corporation

Completed

Activity & Safety Study of Lenalidomide & Rituximab as Non-chemotherapy Based Therapy on Chronic Lymphocytic Leukemia (LLC-LENAR-08)

Chronic Lymphocytic Leukemia

Spain
Kristian Reich, MD
LEO Pharma

Completed

Optimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP) (PSO-TOP)

Mild to Moderate Psoriasis

United Kingdom, Germany, France, Spain, Netherlands, Sweden, Italy, Denmark
Elizabeth K. Lee MD
Merck Sharp & Dohme LLC

Recruiting

Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer

Gynecologic Cancer | Ovarian Clear Cell Carcinoma

United States
H. Lee Moffitt Cancer Center and Research Institute
BeiGene, Ltd.

Recruiting

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

Follicular Lymphoma | Marginal Zone Lymphoma | B-Cell Lymphoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene Corporation

Completed

Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS

Myelodysplastic Syndrome | MDS

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene Corporation

Completed

Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer

Bladder Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene Corporation

Completed

Lenalidomide in Comb w/Rituximab for Pts w/CD5+/CD20+ Hem Malignancies Who Relapse/Progress After Rituximab

Mantle Cell Lymphoma | Lymphocytic Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene Corporation

Completed

Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant

Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
Celgene Corporation

Completed

Maintenance Azacitidine in Elderly Patients With Acute Myeloid Leukemia (AML) in CR After Induction Chemotherapy

Leukemia

United States
Center Eugene Marquis
Ligue contre le cancer, France

Recruiting

Anticipated Personalization of the Management in Day Hospital Unit Based on a Collection of the PROs Via a Digital Tool (ANTICIPRO)

Solid Malignant Tumor

France
Kenneth Peters, MD
Celgene Corporation

Completed

An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Prostatitis | Chronic Prostatitis With Chronic Pelvic Pain Syndrome

United States
Kenneth Peters, MD
Celgene Corporation; William Beaumont Hospitals

Terminated

Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain

Pelvic Pain | Chronic Prostatitis

United States
Mehrdad Abedi, MD
Celgene

Terminated

Phase I Study of Lenalidomide in Patients With Acute Leukemia

Acute Leukemia

United States
Kenneth Peters, MD
Celgene Corporation

Completed

CC-10004 For The Treatment Of Vulvodynia

Vulvodynia

United States
Jeffrey Eugene, MD
Accreditation Council for Graduate Medical Education

Not yet recruiting

The Getting Real About The Talk (GReAT) Project - A Qualitative, Patient-Centered Evaluation of the Factors for Successfully Having 'The Talk' and Implementation for Attending and Trainee Physicians (GReAT)

Self Efficacy
Kiwon Lee MD
JFK Medical Center

Recruiting

Transitions of Care for Stroke Patients

Stroke | Ischemic Stroke | Intracerebral Hemorrhage

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis; Celgene Corporation

Completed

Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Neal D. Bhatia, MD
LEO Pharma

Completed

Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands.

Verruca Vulgaris | Common Warts

United States
H. Lee Moffitt Cancer Center and Research Institute
Novartis; Celgene Corporation

Active, not recruiting

Ofatumumab, High Dose Methylprednisolone, Ofatumumab and Lenalidomide Consolidative Therapy for Untreated CLL/SLL

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Zhang Lei, MD

Recruiting

Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia

Thrombocytopenia | Antiphospholipid Syndrome | Treatment

China
Mikkael Sekeres, MD
Bristol-Myers Squibb; Celgene

Recruiting

Luspatercept and Lenalidomide (L2) in Lower-risk, Non-del(5q) MDS Patients

Myelodysplastic Syndromes

United States
Florian Strasser, MD ABHPM
Celgene

Completed

Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia Syndrome

Cancer Cachexia Syndrome

Switzerland
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; Celgene Corporation

Completed

Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma

Melanoma

United States
Andrew Yee, MD
Janssen Research & Development, LLC; Amgen

Recruiting

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

Multiple Myeloma | Refractory Multiple Myeloma | Relapse | Multiple Myeloma in Relapse

United States

Clinical Trials Sponsored by Eugene Lee, MD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations